Research

MAPPYACTS enables precision medecine for children with therapeutic failure

MAPPYACTS enables precision medecine for children with therapeutic failure

MAPPYACTS enables precision medecine for children with therapeutic failure

Presented at the ASCO annual congress in Chicago in June 2019, the first results of MAPPYACTS, that we have cofunded giving 1.720.000€ thanks to the Children without Cancer races in 2017 and 2019, are promising : for 2/3 of the children whose tumor was analyzed, therapeutical targets could be identified, allowing them to benefit from […]

First results of AcSe-ESMART presented at ASCO

First results of AcSe-ESMART presented at ASCO

First results of AcSe-ESMART presented at ASCO

The therapeutical trial AcSé-ESMART, unique in the world in the pediatric field and that we have co-funded giving 1.832.000€, gives access to 10 personalized and innovative treatments to children in relapse or with therapeutical failure. The French newspaper Le Figaro has summarized this very promising approach in the below article published on the 4th of June of […]

Imagine for Margo at the 2019 AACR in Atlanta

Imagine for Margo at the 2019 AACR in Atlanta

Imagine for Margo at the 2019 AACR in Atlanta

Patricia Blanc, our President who recently became a member of the AACR* Pediatric Working Group, participated, during 5 days, at the 2019 annual AACR congress in Atlanta (USA). This meeting gathered the experts in pediatric oncology research worldwide.    *American Association for Cancer Research   Ou President could participate in four meetings of the Pediatric Committee, […]

FAST 2019 SEMINAR ON RESEARCH AGAINST CHILDREN’S CANCER

FAST 2019 SEMINAR ON RESEARCH AGAINST CHILDREN’S CANCER

FAST 2019 SEMINAR ON RESEARCH AGAINST CHILDREN’S CANCER

The 6th edition of our FAST conference on research took place on Saturday, February 16th, in the Senate in Paris.     This annual meeting, which aims to bring together the main players in pediatric oncology research – doctors, researchers, drug manufacturers, institutions, parliamentarians, politicians, parents’ and patients’ associations, research foundations – was an opportunity […]